Altamira Therapeutics Ltd (CYTO)
1.54
-0.02
(-1.28%)
USD |
NASDAQ |
May 17, 16:00
1.56
+0.02
(+1.30%)
After-Hours: 20:00
Altamira Therapeutics Shareholders Equity (Quarterly): 7.690M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.690M |
| June 30, 2023 | -2.029M |
| June 30, 2023 | -2.029M |
| December 31, 2022 | -8.968M |
| June 30, 2022 | 8.042M |
| June 30, 2022 | 8.042M |
| December 31, 2021 | 14.26M |
| June 30, 2021 | 21.81M |
| June 30, 2021 | 21.81M |
| December 31, 2020 | 19.19M |
| June 30, 2020 | 4.709M |
| June 30, 2020 | 4.709M |
| December 31, 2019 | 6.230M |
| June 30, 2019 | 9.164M |
| December 31, 2018 | 3.707M |
| September 30, 2018 | -0.7551M |
| June 30, 2018 | -3.557M |
| March 31, 2018 | -1.482M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.220M |
| September 30, 2017 | -0.4923M |
| June 30, 2017 | 5.589M |
| March 31, 2017 | 10.55M |
| December 31, 2016 | 13.90M |
| September 30, 2016 | 20.01M |
| June 30, 2016 | 27.65M |
| March 31, 2016 | 37.19M |
| December 31, 2015 | 45.27M |
| September 30, 2015 | 51.42M |
| June 30, 2015 | 59.50M |
| March 31, 2015 | 46.59M |
| December 31, 2014 | 53.88M |
| September 30, 2014 | 60.94M |
| June 30, 2014 | 12.94M |
| March 31, 2014 | 19.03M |
| December 31, 2013 | 43.98M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.968M
Minimum
Dec 2022
21.81M
Maximum
Jun 2021
8.045M
Average
7.866M
Median
Shareholders Equity (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals Ltd | 431.90M |
| Tiziana Life Sciences Ltd | 5.536M |
| Landos Biopharma Inc | 23.15M |
| Masimo Corp | 1.365B |
| AbbVie Inc | 8.007B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.160M |
| Total Liabilities (Quarterly) | 1.471M |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | 31.93% |